Trial Profile
Planned trial of ganetespib + pemetrexed + cisplatin in mesothelioma
Status:
Not stated
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 06 Aug 2013
Price :
$35
*
At a glance
- Drugs Ganetespib (Primary) ; Cisplatin; Pemetrexed
- Indications Mesothelioma
- Focus Therapeutic Use
- 06 Aug 2013 Initiation of this trial is expected later in 2013 or early in 2014, according to a Synta Pharmaceuticals media release.
- 06 Aug 2013 New trial record